4.2 Article

Focal Segmental Glomerulosclerosis and Chronic Kidney Disease in Pediatric Patients

Journal

ADVANCES IN CHRONIC KIDNEY DISEASE
Volume 18, Issue 5, Pages 332-338

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.ackd.2011.03.005

Keywords

FSGS

Funding

  1. NIDDK NIH HHS [R21 DK070341, R33 DK070341-05, R21 DK070341-02, R33 DK070341-04, R33 DK070341-03, R21 DK070341-01, R33 DK070341] Funding Source: Medline

Ask authors/readers for more resources

Focal segmental glomerulosclerosis (FSGS) is one of the most common forms of acquired glomerular disease leading to end-stage kidney disease. Its incidence is rising around the world. There is no proven therapy for those patients who do not respond to corticosteroids and it can recur in 20% to 25% of patients who receive a kidney transplant. The disease can be primary, or it can be secondary to various conditions including vesicoureteral reflux, obesity, medications, and infections. Recent advances have demonstrated the important role of genetic mutations in podocyte proteins as a cause of FSGS. There is an urgent need for randomized clinical trials to develop safe and effective therapy for FSGS that occurs in the native or transplanted kidney. (C) 2011 by the National Kidney Foundation, Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available